January 22nd, 2022

64x Bio's iterative solutions to vector manufacturing pain points​

​

January 19th, 2022

Harvard offshoot 64x Bio nets $55M in series A funding to expand cell production tech

 

January 19th, 2022

A George Church spinout fighting the viral vector bottleneck in cell and gene therapy lands $55M​

​

January 19th, 2022

Here is the 10-slide deck a new biotech company addressing a critical gene- therapy bottleneck used to raise $55 million in just a few months​

​

January 19th, 2022

64x Bio Raises $55M To Advance Gene Therapy Platform​

​

January 19th, 2022

64x Bio Lands $55 Million for Gene-Therapy Tech

​

January 19th, 2022

64x Bio Raises $55 Million Series A Financing to Advance Cell Line Engineering Platform for Gene Therapy Manufacturing

​

November 20th, 2020

George Church backs a startup solution to the massive gene therapy manufacturing bottleneck

​

November 16th, 2020

64x Bio emerges from stealth to drive an evolution in cell and gene therapy manufacturing

​

December 27, 2019

One year, 1 lab, 16 spinouts

​

December 8, 2019

A Harvard geneticist's goal: to protect humans from viruses, genetic diseases, and aging

​

December 3, 2019

The synthetic biology revolution is here

​

November 18, 2019

SynBioBeta: synthetic biology the next big thing after computers

​

November 7, 2019

Harvard scientist’s breakthrough could make humans resistant to all viruses

​

February 26, 2019

What’s in the water at the George Church lab?

 

August 24, 2018

The female-founded startups at Y Combinator Demo Day 2

 

August 22, 2018

At Y Combinator, startups manage molecules rather than code

​

August 22, 2018

The top 10 startups from Y Combinator's Demo Day S18 day 2

​

August 21, 2018

All 59 startups that launched today at Y Combinator's S18 Demo Day 2